tmcnet.com
May 13, 2008
KRT) Via Acquire Media NewsEdge) May 13--A small Durham biotechnology company has filed plans to sell stock to the public, taking a leap of faith that Wall Street is recuperating. Before the deal can happen, the number of shares for sale and the expected price per share must be determined and filed with...
[read full story]